Related Search

Multi-Asset Insights: Is FX adjustment a cure for 'Dutch Disease'?

In this month's Multi-Asset Insights we discuss which countries are suffering from a foreign exchange-led decline in competitiveness, a phenomenon known as 'Dutch Disease'.

23/12/2015

Multi-Asset Investments

What is Dutch Disease and its symptoms?

Following the Netherlands’ discovery of a large natural gas field in the late 1950s, the country’s economic model changed significantly to focus on developing natural resources, leading to a gas export boom.

Capital and labour were allocated to the booming industry, while exports of natural gas brought in a large amount of capital, which pushed up the Dutch guilder.

One of the symptoms of Dutch Disease is that the booming industry crowds out the non resources sectors of the economy.

In the case of the Netherlands, manufacturing’s share of exports and gross value added (GVA) fell significantly given weakened competitiveness following the strong currency appreciation.

Employment in manufacturing contracted subsequently in the 1970s, which was followed by a recession in the early 1980s.

The Economist coined the phrase “Dutch Disease” to describe this phenomenon of a foreign exchange (FX) led decline in competitiveness, referring to this classic example of the Netherlands.

Who in the world has contracted Dutch Disease?

Among others, it looks like Australia and Canada have fallen victim to the disease.

Both countries have seen substantial increases in the importance of their natural resources sectors as they directly fed Chinese demand for raw materials during the nation’s rapid industrialisation.

This created upward pressure on growth and wages and, ultimately, higher interest rates.

The strong appreciation of the Australian and Canadian dollars (AUD and CAD) from 2001 is a classic symptom of Dutch Disease.

In addition, we have also seen the reallocation of capital from manufacturing to natural resources investments – further evidence that Australia and Canada have contracted the disease.

Source: Datastream. Monthly data from January 2000 to October 2015. All indices rebased to value of 100 as of January 2000.

What is the cure for the disease?

The only cure for the Dutch Disease is a substantial adjustment in the real effective exchange rate to revive those areas of the economy which previously suffered from the overvaluation of the exchange rate.

Since the peak of the commodity super-cycle and the subsequent peak in resource investment, we have seen exchange rates adjust lower as terms of trade have collapsed and interest rates have been cut to support growth.

G10 commodity currencies have depreciated by roughly 25-35% vs the US dollar and 20-30% in REER terms since 2010’s peak in commodity prices.

What is our diagnosis for patients AUD and CAD?

In Australia, we believe further adjustments are required for the disease to be cured.

Currently the investment in the mining sector is at 4% of GDP.

While this represents a significant drop from 6.5% at its peak, we believe it needs to fall to the long-term average of 1.5% of GDP.

This is likely to outweigh any recovery in manufacturing investment, which has yet to show signs of picking up.

As a result, growth and inflation are likely to remain weak, putting downward pressure on interest rates which push the AUD REER further down to allow manufacturing investment to begin to recover.

We estimate a further 20% potential downside to the AUD given the severity of its disease.

Chart 2: Australia manufacturing / mining investment (% GDP)

Source: Datastream. Monthly data from December 1987 to June 2015

Our patient CAD looks a little better, as there are some signs that exchange rate sensitive sectors are beginning to pick up, for example the increasing volume of automotive exports.

Though modest, it appears that Canada is further down the road to rebalancing.

However, there are also signs that economic activity is shifting from natural resources to credit and housing given declining interest rates.

Given the significant imbalances in Canada’s housing market, this form of rebalancing is unlikely to be sustainable.

For this patient, our diagnosis is that a further 10% depreciation in the CAD is possible.

Chart 3: Canadian energy & automotive as % of exports

Source: Datastream. Monthly data from December 1997 to September 2015

While the healing process for the AUD and CAD has started, we believe there is still some way to go.

As such, we remain structurally bearish on these currencies until they show signs of health again.

The information on this website is intended solely for use by Singapore residents.

The funds mentioned are Singapore- authorised and recognised funds registered for sale or purchase in Singapore. By proceeding you are representing and warranting that you are either resident in Singapore or the applicable laws and regulations of your jurisdiction allow you to access the information. In particular, the information is not for distribution and does not constitute an offer to sell or the solicitation of an offer to buy units in Schroder funds in any jurisdiction where such activity is prohibited including the United States of America.

The contents on this website are for information only and without consideration given to the specific investment objective, financial situation and particular needs of any specific person. You may wish to seek advice from a financial advisor before purchasing units of any Schroder fund. In the event that you choose not to seek advice from a financial advisor before investing in any fund, you should consider whether the fund selected is suitable for you.

Past performance and any forecasts are not necessarily indicative of future performance. The value of units and the income from them may fall as well as rise. The funds are subject to investment risks. You should read the relevant prospectus obtainable from this website before investing.

The material and information on this site is current at the date of publication and is provided on an "AS IS" basis and without without any warranties of any kind, either expressed or implied.

To the best of the knowledge, information and belief of Schroder Investment Management (Singapore) Ltd ("SIMSL"), all information contained herein is accurate as at the date of publication. However, SIMSL or its affiliates or any director or employee of SIMSL or its affiliates cannot and does not warrant, guarantee or represent, either expressly or by implication, the accuracy, validity or completeness of such information.

Under no circumstances may the information contained herein, or any part thereof, be copied, reproduced or redistributed without the express permission of SIMSL. SIMSL or its affiliates, any directors or employees of SIMSL or its affiliates shall not be liable for any damages arising from any person's reliance on such information and shall not be liable for any errors or omissions (including but not limited to errors or omissions made by third parties) in such information. The information provided herein is subject to change without further notice.

Schroder Investment Management (Singapore) Ltd is regulated by the Monetary Authority of Singapore and is a member of the Investment Management Association of Singapore (IMAS).

We use cookies to help improve your experience with this website. By using this site, you agree that we may store and access cookies on your device. Cookies are small text files, downloaded onto your device, that tell us which pages you've visited, when and what your technology preferences are. To find out more about the cookies that we use, their purpose and how you can manage them, please visit: How we use Cookies

MSCI Disclaimer

Source: MSCIThe information obtained from MSCI and other data providers, included in reports available from this website, may only be used for your internal use, may not be reproduced or re-disseminated in any form and may not be used to create any financial instruments or products or any indices. The MSCI information and that of other data providers is provided on an “as is” basis and the user of this information assumes the entire risk of any use made of this information. MSCI, each of its affiliates and each other person involved in or related to compiling or creating any MSCI information (collectively, the “MSCI Parties”) and other data providers, expressly disclaim all warranties (including, without limitation any warranties of originality, accuracy, completeness, timeliness, non-infringement, merchantability and fitness for a particular purpose) with respect to this information. Without limiting any of the foregoing, in no event shall any MSCI Party or other data provider have any liability for any direct, indirect, special, incidental, punitive, consequential (including, without limitation, lost profits) or any other damages.